226 related articles for article (PubMed ID: 22286757)
21. MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.
Lin Y; Chen Z; Lin S; Zheng Y; Liu Y; Gao J; Chen S
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):598-606. PubMed ID: 31058289
[TBL] [Abstract][Full Text] [Related]
22. Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis.
Zhou L; Zhao X; Han Y; Lu Y; Shang Y; Liu C; Li T; Jin Z; Fan D; Wu K
FASEB J; 2013 Dec; 27(12):4929-39. PubMed ID: 23982143
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.
Kai M; Yamamoto E; Sato A; Yamano HO; Niinuma T; Kitajima H; Harada T; Aoki H; Maruyama R; Toyota M; Hatahira T; Nakase H; Sugai T; Yamashita T; Toyota M; Suzuki H
Mol Carcinog; 2017 Jul; 56(7):1743-1752. PubMed ID: 28218473
[TBL] [Abstract][Full Text] [Related]
25. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy.
Wan X; Yang S; Huang W; Wu D; Chen H; Wu M; Li J; Li T; Li Y
J Exp Clin Cancer Res; 2016 Feb; 35():34. PubMed ID: 26884069
[TBL] [Abstract][Full Text] [Related]
26. UHRF1 regulates CDH1 via promoter associated non-coding RNAs in prostate cancer cells.
Magnani E; Macchi F; Mancini M; Lomazzi V; Cogliati S; Pistore C; Mandruzzato M; Dock-Bregeon AC; Bonapace IM
Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):258-270. PubMed ID: 29466696
[TBL] [Abstract][Full Text] [Related]
27. Functional dissection of the role of UHRF1 in the regulation of retinoblastoma methylome.
Kan G; He H; Zhao Q; Li X; Li M; Yang H; Kim JK
Oncotarget; 2017 Jun; 8(24):39497-39511. PubMed ID: 28467809
[TBL] [Abstract][Full Text] [Related]
28. UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics.
Sidhu H; Capalash N
Tumour Biol; 2017 Feb; 39(2):1010428317692205. PubMed ID: 28218043
[TBL] [Abstract][Full Text] [Related]
29. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
30. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
31. UHRF1 Promotes Proliferation of Human Adipose-Derived Stem Cells and Suppresses Adipogenesis via Inhibiting Peroxisome Proliferator-Activated Receptor
Chen K; Guo Z; Luo Y; Yuan J; Mo Z
Biomed Res Int; 2019; 2019():9456847. PubMed ID: 31428652
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
33. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.
Unoki M; Brunet J; Mousli M
Biochem Pharmacol; 2009 Nov; 78(10):1279-88. PubMed ID: 19501055
[TBL] [Abstract][Full Text] [Related]
34. UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells.
Zhang Q; Qiao L; Wang X; Ding C; Chen JJ
Cell Cycle; 2018; 17(3):300-308. PubMed ID: 29157076
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulator UHRF1 inactivates REST and growth suppressor gene expression via DNA methylation to promote axon regeneration.
Oh YM; Mahar M; Ewan EE; Leahy KM; Zhao G; Cavalli V
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12417-E12426. PubMed ID: 30530687
[TBL] [Abstract][Full Text] [Related]
36. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.
Friedrich T; Söhn M; Gutting T; Janssen KP; Behrens HM; Röcken C; Ebert MPA; Burgermeister E
EBioMedicine; 2016 Jun; 8():159-172. PubMed ID: 27428427
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic changes in colorectal cancer.
Kondo Y; Issa JP
Cancer Metastasis Rev; 2004; 23(1-2):29-39. PubMed ID: 15000147
[TBL] [Abstract][Full Text] [Related]
38. mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.
Zafari V; Hashemzadeh S; Hosseinpour Feizi M; Pouladi N; Rostami Zadeh L; Sakhinia E
Bosn J Basic Med Sci; 2017 Aug; 17(3):255-261. PubMed ID: 28504924
[TBL] [Abstract][Full Text] [Related]
39. PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil.
Schöckel L; Woischke C; Surendran SA; Michl M; Schiergens T; Hölscher A; Glass F; Kreissl P; Klauschen F; Günther M; Ormanns S; Neumann J
BMC Cancer; 2024 Feb; 24(1):234. PubMed ID: 38378472
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.
Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H
Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
